Core Viewpoint - Shanghai Meino Biological Technology Co., Ltd. is undergoing a review of its stock incentive plan to ensure compliance with relevant regulations and to protect the interests of shareholders [1][2][3]. Compliance with Listing Company Requirements - The financial report for the most recent accounting year did not receive a negative opinion or inability to express an opinion from the registered accountant [1]. - There have been no instances in the last 36 months where profit distribution did not comply with laws, regulations, or company articles [1]. Compliance of Incentive Objects - The incentive plan does not include shareholders or actual controllers holding more than 5% of the company's shares [1]. - No significant violations leading to administrative penalties from the China Securities Regulatory Commission (CSRC) have occurred in the last 12 months [1]. Compliance of Incentive Plan - The total number of shares involved in all effective stock incentive plans does not exceed 20% of the company's total equity [1]. - The reserved rights for incentive objects do not exceed 20% of the proposed rights to be granted in this stock incentive plan [1]. Disclosure Completeness of Incentive Plan - The plan's purpose, criteria for determining incentive objects, and the range of those objects have been clearly stated [1]. - The number of rights to be granted and their percentage of the company's total equity have been disclosed, including any reserved rights [1]. - The plan includes details on the effective period, authorization date, and lock-up arrangements [1]. Performance Assessment Indicators - Performance assessment indicators are objective, public, clear, and beneficial for enhancing the company's competitiveness [4]. - At least three comparable companies from the same industry have been selected for benchmarking [4]. Compliance of Lock-up and Vesting Periods - The interval between the authorization date of restricted stock and the first lifting of restrictions is not less than one year [4]. - The proportion of stock options that can be exercised in each period does not exceed 50% of the total stock options granted to the incentive objects [4]. Professional Opinions and Legal Compliance - The remuneration and assessment committee has provided opinions on whether the stock incentive plan benefits the company's sustainable development [4]. - The company has engaged a law firm to issue a legal opinion in accordance with the Stock Incentive Management Measures [4].
美农生物: 股权激励计划自查表